As we move into January xxxx, the U.S. market is witnessing an anticipated decline in import prices for Povidone, followed by the trend of the previous month i.e., December xxxx. Povidone, a key excipient used across pharmaceutical, cosmetic, and food industries, has been closely monitored in recent months due to fluctuations in its price and demand. The projected drop in import prices stems from the ongoing stabilization of key cost drivers, including feedstock prices, supply chain improvements, and a potential easing in global freight costs.
One of the primary factors supporting the expected reduction in import prices is the softening of the demand side. On the demand side, while the pharmaceutical industry remains a stable consumer of Povidone, there has been a shift in the demand dynamics over the past months, leading to weaker-than-anticipated quotations arriving from the end-users. These industries have faced a slowdown due to...
